Catalyst Wire Dossier Catalyst Wire Dossier

Dendritic Cells Plus Autologous Tumor RNA

· University Hospital Erlangen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dendritic Cells Plus Autologous Tumor RNA, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma [Phase 3]

See pricing